Chargement en cours...
Pazopanib and Statin-Induced Rhabdomyolysis
BACKGROUND: The VEGF inhibitor pazopanib is a widely used first-line therapy for the treatment of advanced renal cell carcinoma. Potential drug-drug interactions and toxicities may be underrecognized. CASE PRESENTATION: A 73-year-old woman with metastatic renal cell carcinoma on treatment with pazop...
Enregistré dans:
| Publié dans: | Case Rep Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731169/ https://ncbi.nlm.nih.gov/pubmed/29279698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481659 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|